The Prevalence of Sacroiliitis and Spondyloarthritis in Patients with Sarcoidosis
Author(s) -
Şenol Kobak,
Fidan Sever,
Özlem İnce,
Mehmet Orman
Publication year - 2014
Publication title -
international journal of rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.8
H-Index - 33
eISSN - 1687-9279
pISSN - 1687-9260
DOI - 10.1155/2014/289454
Subject(s) - medicine , sarcoidosis , sacroiliitis , dactylitis , enthesitis , dermatology , psoriasis , uveitis , back pain , spondylitis , disease , ankylosing spondylitis , psoriatic arthritis , pathology , immunology , alternative medicine
. Sarcoidosis is a chronic granulomatous disease, which can involve different organs and systems. Coexistence of sarcoidosis and spondyloarthritis has been reported in numerous case reports. Purpose. To determine the prevalence of sacroiliitis and spondyloarthritis in patients previously diagnosed with sarcoidosis and to investigate any possible relation with clinical findings. Materials and Methods. Forty-two patients with sarcoidosis were enrolled in the study. Any signs and symptoms in regard to spondyloarthritis (i.e., existence of inflammatory back pain, gluteal pain, uveitis, enthesitis, dactylitis, inflammatory bowel disease, and psoriasis) were questioned in detail and biochemical tests were evaluated. Sacroiliac joint imaging and lateral heel imaging were performed in all patients. Results. Sacroiliitis was found in 6 of the 42 (14.3%) sarcoidosis patients and all of these patients were female. Common features of the disease in these six patients were inflammatory back pain as the major clinical complaint, stage 2 sacroiliitis as revealed by radiological staging, and the negativity of HLA B-27 test. These six patients with sacroiliitis were diagnosed with spondyloarthritis according to the criteria of ASAS and of ESSG. Conclusion. We found spondyloarthritis in patients with sarcoidosis at a higher percentage rate than in the general population (1–1.9%). Controlled trials involving large series of patients are required for the confirmation of the data.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom